Response letter to "Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers"

被引：0
|
作者：
Ichimura, Takenori [1 ,2 ]
机构：
[1] Univ Sch Pharm, Dept Hosp Pharmaceut, Tokyo, Japan
[2] Showa Univ, Dept Hosp Pharmaceut, Sch Pharm, 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2023年 / 29卷 / 04期
关键词：
GEMCITABINE; CISPLATIN;
D O I：
10.1177/10781552231165235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1025 / 1026
页数：2
相关论文
共 50 条
  • [41] FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers
    Nichetti, F.
    Rizzato, M.
    Bensi, M.
    Salani, F.
    Franza, A.
    Piva, V.
    Cerantola, R.
    Chiaravalli, M.
    Masi, G.
    Djaballah, S. Ahcene
    Barone, D.
    Vivaldi, C.
    Bergamo, F.
    Rota, S.
    Di Bartolomeo, M.
    de Braud, F.
    Niger, M.
    Lonardi, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S113 - S113
  • [42] Second-line chemotherapy (SLC) in patients with advanced biliary tract and gallbladder cancers (ABGC) prolongs survival: A retrospective population-based cohort study
    Zaidi, A.
    Chandna, N.
    Narasimhan, G.
    Moser, M.
    Haider, K.
    Chalchal, H. I.
    Shaw, J.
    Ahmed, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] Second-line chemotherapy in biliary tract cancer: Outcome and prognostic factors
    Schweitzer, Nora
    Kirstein, Martha M.
    Kratzel, Anna-Maria
    Mederacke, Young-Seon
    Fischer, Mareike
    Manns, Michael P.
    Vogel, Arndt
    LIVER INTERNATIONAL, 2019, 39 (05) : 914 - 923
  • [44] Prognostic impact of response to second-line chemotherapy on overall survival of patients with advanced gastric cancer
    Kim, S.
    Hwang, M.
    Park, Y.
    Park, S.
    Kim, Y.
    Ryu, K.
    Lee, J.
    Park, Y.
    Kim, N.
    Park, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Outcomes of second line treatment in patients with advanced and metastatic biliary cancers.
    Westin, Gustavo Figueiredo Marcondes
    Alsidawi, Samer
    Chandrasekharan, Chandrikha
    Briggler, Andrew M.
    Huffman, Brendon
    Pallante, Angeline
    Hubbard, Joleen Marie
    Alberts, Steven R.
    Halfdanarson, Thorvardur Ragnar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Oyama, Hiroki
    Kanai, Sachiko
    Suzuki, Tatsunori
    Sato, Tatsuya
    Hakuta, Ryunosuke
    Ishigaki, Kazunaga
    Takeda, Tsuyoshi
    Saito, Tomotaka
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (06) : 1093 - 1102
  • [47] Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases
    Naminatsu Takahara
    Yousuke Nakai
    Hiroyuki Isayama
    Takashi Sasaki
    Kei Saito
    Hiroki Oyama
    Sachiko Kanai
    Tatsunori Suzuki
    Tatsuya Sato
    Ryunosuke Hakuta
    Kazunaga Ishigaki
    Tsuyoshi Takeda
    Tomotaka Saito
    Suguru Mizuno
    Hirofumi Kogure
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2018, 36 : 1093 - 1102
  • [48] SECOND-LINE CHEMOTHERAPY WITH S-1 AFTER CISPLATIN AND GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Ueda, Shinya
    Kawakami, Hisato
    Okamoto, Wataru
    Nishina, Shinichi
    Kudo, Toshihiro
    Makimura, Chihiro
    Kiyota, Hidemi
    Tanaka, Kaoru
    Kaneda, Hiroyasu
    Fujisaka, Yasuhito
    Miyazaki, Masaki
    Turutani, Junji
    Okamoto, Isamu
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [49] Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract Cancer
    Frega, Giorgio
    Palloni, Andrea
    Deiana, Chiara
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Brandi, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [50] Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Tober, Nastassja
    Nigro, Maria Concetta
    Mosca, Mirta
    Palloni, Andrea
    Abbati, Francesca
    Frega, Giorgio
    De Lorenzo, Stefania
    Tavolari, Simona
    Brandi, Giovanni
    ANTICANCER RESEARCH, 2020, 40 (06) : 3013 - 3030
12345